CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-15 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,812 | 43,989 | ||
| 2024-04-15 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,427 | $11.89 | $17K | 42,562 |
| 2024-04-15 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,812 | 8,439 | ||
| 2024-04-15 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,812 | 39,453 | ||
| 2024-04-15 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,427 | $11.89 | $17K | 38,026 |
| 2024-04-15 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,812 | 8,439 | ||
| 2024-03-04 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +15,623 | 49,230 | ||
| 2024-03-04 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −8,053 | $16.96 | $137K | 41,177 |
| 2024-03-04 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −15,623 | 31,252 | ||
| 2024-03-04 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +41,662 | 140,800 | ||
| 2024-03-04 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −11,449 | $16.96 | $194K | 129,351 |
| 2024-03-04 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −41,662 | 83,338 | ||
| 2024-03-04 | BILINSKY IGOR Chief Operating Officer | Option exercise | +14,061 | 43,928 | ||
| 2024-03-04 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −7,287 | $16.96 | $124K | 36,641 |
| 2024-03-04 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −14,061 | 28,129 | ||
| 2024-03-01 | YARNO WENDY L Director | Grant or award · Deferred Restricted Stock Unit | +25,000 | 25,000 | ||
| 2024-03-01 | Rothbaum Wayne P. Director | Grant or award · Deferred Restricted Stock Unit | +100,000 | 100,000 | ||
| 2024-03-01 | Vogt Frederick G Interim CEO & General Counsel | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2024-03-01 | Vogt Frederick G Interim CEO & General Counsel | Grant or award · Restricted Stock Units | +93,750 | 93,750 | ||
| 2024-03-01 | Maynard Ryan D Director | Grant or award · Deferred Restricted Stock Unit | +50,000 | 50,000 |
Page 15 of 23 · 446 trades